Unit Biological Safety officer, Unit and School Radiological Safety Officer.
Member of School Safety Committee and Joint School/NHS Safety Committee, College Safety Committee and College Laboratories Committee, University Biological Safety Committee and University Health and Safety Committee
Trained UCU Health and Safety Rep. DUCU Health and Safety Rep.
Cell motility of tumour and associated cells, the role of the extracellular matrix and cytokines (growth factors) in the control of cell behaviour, signal transduction pathways that affect cell motility, and inhibition of cell motility- with a view to being able understand the control cell migration.
- 1st BDS Cell Biology Modules
- 2nd BDS Development Biology and Dental Tissue Modules
- BMSc Laboratory Supervisor
- MRes Supervisor
- PhD Supervisor
GALLOWAY, J. L., JONES, S. J., MOSSEY, P. A. & ELLIS, I. R. (2013) The control and importance of hyaluronan synthase expression in palatogenesis. Frontiers in Physiology. 4, 11 p., 10
ELLIS IR, ISLAM M, ALJORANI L and JONES SJ. Fibronectin: the N terminal region and its role in cell migration- implications for disease and healing. In Fibronectin: Structure, Function, Pathology. Nova Publishers. Editor James Beattie.
SCHOR S.L., ELLIS IR, JONES SJ, WOOLSTON AM, and SCHOR AM. Bi-stable switch in MSF expression is regulated by concerted signalling of TGFβ and matrix: potential impact on tumour progression. Int J Cancer. 2012 May 1;130(9):2024-32.
ALJORANI, LA, CAREY F, BANKFALVI A, OHE G, JONES, SJ, ELLIS IR, SCHOR Sl, SCHOR AM. Migration stimulating factor as a novel biomarker in salivary gland tumours. Journal of Oral Path. and Med. : Epub ahead of publication
MARHENBERG ZR, ELLIS IR, HAGAN RM, PRABHAKARAN S, HOOK M, TALAY SR, POTTS JR, STAUNTON D & SCHWARZ-LINEK U (2011) Cooperative binding and activation of fibronectin by a bacterial surface protein. J. Biol Chem. 2011 Jan 21; 286(3):1884-94.
ELLIS IR, JONES SJ, STAUNTON D, VAKONAKIS I, NORMAN DG, POTTS JR, MILNER CM, MEENAN NAG, RAIBAUD S, SCHOR AM & SCHOR SL (2010) Multi-factorial modulation of IGD motogenic potential in MSF (Migration Stimulating Factor). Exp Cell Res 316, 15, 2465-76.
ELLIS IR, JONES SJ, LINDSAY Y, OHE G, SCHOR AM, SCHOR SL & LESLIE NR (2010) Migration Stimulating Factor (MSF) promotes fibroblast migration by inhibiting AKT. Cell Signal 22(11), 1655-9.
SCHOR AM, PERRIER S, WOOLSTON AM, JONES SJ, ELLIS IR, ISLAM MR, KAZMI S, PURDIE C, THOMPSON AM & SCHOR SL. (2010) Expression of migration stimulating factor in breast tissues and its clinical significance. Breast Cancer Research, 12, Suppl 1, p37.
SCHOR S.L L. SCHOR A. M. ELLIS I. R. JONES S. J. FLORENCE M. M. COX J. & WOOLSTON A. M. (2009). The oncofetal paradigm revisited: MSF and HA as Contextual Drivers of Cancer Progression. In Hyaluronan in Cancer Biology editor Robert Stern pp. 283-306.
VAKONAKIS I, STAUNTON D, ELLIS IR, SARKLES P, FLANAGAN A, SCHOR AM, SCHOR SL & CAMPBELL ID (2009) Motogenic sites in human fibronectin are masked by long range interactions. J Biol Chem, 284, 23, 15668-15675.
MOTEGI K, HARADA K, OHE G, JONES SJ, ELLIS IR, CROUCH DH, SCHOR SL & SCHOR AM (2008) Differential involvement of TGF-B1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells. Exp Cell Res, 314, 2323-2333.
PATEL BA, ARUNDELL M, QUEK RG, HARVEY SL, ELLIS IR, FLORENCE MM, CASS AE, SCHOR AM & O’HARE D. (2008) Individually addressable microelectrode array for monitoring oxygen and nitric oxide release. Anal Bioanal Chem, 390, 1379-1387.
SCHOR AM, ELLIS IR, JONES SJ, PERRIER S, FLORENCE MM, COX J, OHE G, KANKOVA K, VOJTESEK B, THOMPSON AM, PURDIE C, KAZMI S, FOO S, WOOLSTON AM & SCHOR SL. (2008) Identification and role of migration stimulating factor isoforms in breast carcinomas. Breast Can Res, 10, 66.